Gamma Hydroxybutyrate (GHB) and Gamma Butyrolactone (GBL) Withdrawal
Five Case Studies
Bibliographic Data
| ID | 13913691 |
|---|---|
| Authors | Charles H McDaniel (corresponding author), Karen Miotto (0000-0003-0252-6383, Neurobehavioral Systems), Karen A Miotto |
| Year | 2001 |
| Volume | 33 |
| Issue | 2 |
| Pages | 143-149 |
| Publication date | 2001-06-01 |
| Open Access | No |
| Type | ARTICLE |
| Venue | Journal of Psychoactive Drugs (JOURNAL) |
| Journal identifiers | ISSN: 0279-1072 • E-ISSN: 2159-9777 |
| Publisher | Taylor & Francis (PUBLISHER • GB) |
| DOI | 10.1080/02791072.2001.10400479 |
| PMID | 11476261 |
| OpenAlex | W1998425972 |
| Language | EN |
| Citations received | 3 |
| References cited | 29 |
There is little medical information available about gamma-hydroxybutyrate (GHB) or gamma-butyrolactone (GBL) dependence or withdrawal. In this study the authors treated and reviewed multiple cases of GHB and GBL withdrawal in high-dose users. Five patients during nine hospitalizations were treated for GHB or GBL withdrawal. The authors describe a spectrum of GHB or GBL withdrawal from mild to severe and discuss medications used for treatment. They conclude that patients with GHB or GBL withdrawal may present with agitated psychosis, delirium, and autonomic instability. In this sample, relapse to GHB or GBL use occurred soon after treatment of withdrawal
Anesthesia · Delirium · Gamma hydroxybutyrate · Psychiatry · Psychosis · Alcohol Consumption and Health Effects · Forensic Toxicology and Drug Analysis · Medicine · Neurotransmitter Receptor Influence on Behavior · Psychology
| Citations per year | 0.14 |
|---|---|
| Citation span | 2004 - 2026 (23) |
| Highly cited | No |